Mercury is an established worldwide environmental pollutant with well-known toxicity affecting neurodevelopment in humans, but the molecular basis of cytotoxicity and the detoxification procedure are still unclear. Here we examined the involvement of the canonical transient receptor potential (TRPC) channel in the mercury-induced cytotoxicity and the potential detoxification strategy. Whole-cell and excised patches, Ca 21 imaging, and sitedirected mutagenesis were used to determine the mechanism of action of mercurial compounds on TRPC channels overexpressed in HEK293 cells, and cytotoxicity and preventive effect were investigated in cell culture models using small interfering RNA and pharmacological blockers. Mercury potently activates TRPC4 and TRPC5 channels. The extracellular cysteine residues (C 553 and C 558 ) near the channel pore region of TRPC5 are the molecular targets for channel activation by mercury. The sensitivity of mercury to TRPC5 is presumed to be specific because other divalent heavy metal pollutants, such as Cd 21 , Ni 21 , and Zn 21 , had no stimulating effect, and TRPC3, TRPC6, TRPV1, and TRPM2 were resistant to mercurial compounds. The channel activity of TRPC5, as well as TRPC4, induced by mercury, was prevented by 2-aminoethoxydiphenyl borate and modified by a reducing environment. The inhibition of TRPC5 channels by specific TRPC5 pore-blocking antibody or by SKF-96365 alleviated the cytotoxicity, whereas the mercury chelator, meso-2,3-dimercaptosuccinic acid, showed nonselective prevention of cell survival. Silencing of the TRPC5 gene reduced the mercury-induced neuronal damage. These results indicate that mercurial compounds are activators for TRPC5 and TRPC4 channels. Blockade of TRPC channels could be a novel strategy for preventing mercury-induced cytotoxicity and neurodevelopment impairment.
Despite increasing attempts to control industrial pollution, mercury poisoning still occurs through methylmercury (MeHg) from fish, ethylmercury from vaccine products, metallic mercury from dental amalgam fillings, cinnabar from Chinese herbal balls, and other domestic mercury pollution (Counter and Buchanan, 2004) . There are three primary forms of mercury in the environment, that is, metallic, inorganic, and organic mercury. They can convert from one form to another in the environment and in the human body. Three forms show different clinical toxicological features including major damage to the brain by organic mercury, the kidney by inorganic divalent mercury, and the lungs by inhalation of mercury vapor, although many organs are susceptible to mercury exposure (Clarkson et al., 2003) . Young children are vulnerable to mercury exposure, which may cause the impairment of brain development and mental retardation (Costa et al., 2004; Trasande et al., 2005) . In the elderly, the elevated mercury level in the blood has been suggested as a potential risk factor for cardiovascular and neurodegenerative diseases (Guallar et al., 2002; Landrigan et al., 2005) .
MeHg exposure is of particular concern because of its high accumulation in fish, complete absorption from gastrointestinal tract, easy transportation across the placenta and blood-brain barrier, and tissue accumulation. MeHg can affect brain development in children and result in a lower IQ; however, the correlation of MeHg exposure to children's learning and performance capacity is still disputed, as the recent epidemiological studies from the Faroe Island, the Seychelles, and New Zealand have produced contradictory results (Axelrad et al., 2007; Cohen et al., 2005; Davidson et al., 2011; Spurgeon, 2006) . The mechanisms of how MeHg causes brain damage may include abnormality of neuronal migration, neuronal apoptosis, retraction of growth cone formation and extensions, and the loss of interneuronal contacts (Costa et al., 2004) . The network connections between neurons are critical for shortterm and long-term memories, which require a series of biophysical and biochemical processes (Dasari and Yuan, 2009) . Ca 2þ is a second messenger in the processes and plays an essential role in axonal transport, growth cone motility, and extension (Zheng, 2000) . The disturbance of Ca 2þ homeostasis has been linked to mercury toxicity; for example, MeHg blocks voltage-gated Ca 2þ channels (VGCC) but increases intracellular [Ca 2þ ] in isolated nerve terminals (Limke et al., 2004) ; MeHg inhibits the action potential-evoked neurotransmitter release but increases the spontaneous transmitter release (Denny and Atchison, 1996) . These observations suggest that an unidentified Ca 2þ influx pathway might exist. Canonical transient receptor potential (TRPC) channels are Ca 2þ -permeable cationic channels. Seven members (TRPC1-7) have been identified in the TRPC subfamily, and TRPC2 is a pseudogene in human (Clapham, 2003) . TRPC1, TRPC3, and TRPC6 have been shown to mediate chemotropic-guided axonal turning (Li et al., 2005; Wang and Poo, 2005) , and TRPC3 and TRPC6 are also involved in the survival of cerebellum granule neuron (Jia et al., 2007) . TRPC5 channel is highly expressed in the brain, which is encoded by the TRPC5 gene located in a region of human X-chromosome associated with nonsyndromic mental retardation, and thus, there is a putative genetic link with neuronal development (SosseyAlaoui et al., 1999) . It has also been shown that TRPC5 is involved in retardation of neurite outgrowth (Greka et al., 2003; Hui et al., 2006) and in vivo neurofunction (Riccio et al., 2009) . Because TRPC channels play important roles in neuronal function and are critical for regulating Ca 2þ homeostasis in a cell, we then hypothesized that TRPC channels could be important for the mechanisms of mercuryinduced cytotoxicity and neuronal impairment.
In this study, we have examined the effect and underlying mechanism of TRPC channels acting as the molecular targets of mercury-evoked cytotoxicity. We found that mercurial compounds potently activated TRPC5 as well as TRPC4 channels via binding to the two extracellular cysteine residues near the channel pore. Silence of TRPC5 gene with small interfering RNA (siRNA) or blockade of TRPC channel activity with pharmacological tools alleviated the mercury-related cytotoxicity.
MATERIALS AND METHODS
Cell culture, cloning, and transfection. HEK-293 cells were transfected with human TRPC5 (accession number AF054568), TRPC3 (accession number U47050), TRPC6 (accession number BC093660), mouse TRPC4 (accession number NM_016984), mouse TRPM2 (NM_138301), and human TRPV1 (accession number AY131289) plasmid complementary DNAs (cDNAs) in a pcDNA3 vector using Lipofectamine 2000 (Invitrogen, U.K.). The procedure was previously described (Xu et al., 2005b) . The stable transfected cells for TRPC3, TRPC6, TRPV1, and TRPM2 were selected and maintained in the cell culture medium containing G418 (400 lg/ml). The human TRPC4a (NM_016179) tagged with enhanced yellow fluorescent protein in a tetracycline-regulatory vector was stably expressed in HEK-293 T-REx cells (Invitrogen). For some electrophysiological experiments, the tetracyclineinducible TRPC5 cells were used as we reported (Xu et al., 2005a (Xu et al., , 2005b Zeng et al., 2004) , where the expression of TRPC5 was induced by 1 lg/ml tetracycline for 24-72 h before recording. There was no difference in the current-voltage (IV) curve and Ca 2þ influx response to stimuli for the TRPC5 stable cells and the tetracycline-induced TRPC5 cells. The noninduced cells without addition of tetracycline or the nontransfected cells were used as control. Cells were grown in Dulbecco's Modified Eagle Medium (DMEM)-F12 (Gibco, U.K.) medium containing 10% fetal calf serum (FCS), 100 units/ml penicillin, and 100 lg/ml streptomycin. Cells were maintained at 37°C under 95% air and 5% CO 2 and seeded on coverslips prior to experiments.
PC12 cells were grown in F12 medium containing 15% FCS and 50 ng/ml of nerve growth factor (NGF; Invitrogen) using collagen type IV-coated cell culture dishes (Hui et al., 2006) . The cell number and axonal growth were measured manually on photos taken by a digital microscope camera (Nikon, Japan). The TRPC5 siRNA was purchased from Sigma (U.K.) and the effectiveness was validated by real-time PCR as described in a previous publication (Xu et al., 2008a) . The electroporation was used for PC12 cell transfection using BTX Electro Square Porator ECM 830 with three pulses (Genetronics, San Diego, CA) and the efficiency achieved~85% at optimal conditions. Primary cell cultures. The isolation and culture of human umbilical vein endothelial cells (HUVECs) were similar to that published previously (Xu et al., 2008b) . Patients gave informed consent in accordance with the Declaration of Helsinki, and the project was approved by the local ethical committee. Briefly, the isolated cells were cultured in a T-75 flask with endothelial cell growth media (PromoCell, Germany) supplemented with 2% FCS, 5.0 ng/ml epidermal growth factor, 0.5 ng/ml vascular endothelial growth factor, 10 ng/ml basic fibroblast factor, 20 ng/ml insulin-like growth factor-1, and 22.5 ng/ml heparin. Cells were kept at 37°C in a CO 2 incubator with a humidified atmosphere of 5% CO 2 in air and used at passages 2-3. Cells were seeded into 96-or 48-well cell culture plates at a density of 3.0 3 10 4 cells/ml and cultured for 15 h to allow the cells to attach before further treatments.
Electrophysiology and fluorescence measurements. Voltage clamp was performed at room temperature (23-26°C) with the whole-cell, outside-out, or inside-out patch configuration . Briefly, signal was amplified with an Axopatch 200B patch clamp amplifier and controlled with pClamp software 10. A 1-s ramp voltage protocol from -100 to þ100 mV was applied at a frequency of 0.1 Hz from a holding potential of -60 mV. Signals were sampled at 3 kHz and filtered at 1 kHz. The salt-agar bridge was used to connect the ground wire (Ag-AgCl) in the bath chamber. The 200nM Ca 2þ -buffered pipette solution (115 CsCl, 10 ethylene glycol-bis(2-aminoethylether)-N,N,N#,N#-tetraacetic acid, 2 MgCl 2 , 10 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid [HEPES] , and 5.7 CaCl 2 in mM, pH was adjusted to 7.2 with CsOH and osmolarity was adjusted to~290 mOsm with mannitol, and the calculated free Ca 2þ was 200nM) was used. The standard bath solution contained (mM): 130 NaCl, 5 KCl, 8 D-glucose, 10 HEPES, 1.2 MgCl 2 , and 1.5 CaCl 2 . The pH was adjusted to 7.4 with NaOH. The recording chamber had a volume of 150 ll and was perfused at a rate of about 2 ml/min.
For fluorescence measurements, HEK-293 cells transfected with individual genes were incubated with Fluo3-AM (5lM) for 30 min at room temperature in Ca 2þ -free standard bath solution. Intracellular Ca 2þ experiments were performed using cuvette-based [Ca 2þ ] i assay. Briefly, the loaded cells were washed and resuspended in standard bath solution. Volumes of 2 ml were pipetted into a cuvette as required and equilibrated to 22°C (3 min) in the chamber of a Perkin Elmer LS50B fluorimeter. The ratio of Ca 2þ dye fluorescence (Fura-PE3 AM, F 340 /F 380 ) was measured by a Nikon Ti-E system with NIS-Element Ca 2þ imaging software. All the experiments were performed at room temperature.
Western blotting. The protocol was similar to that described previously (Xu et al., 2008a) . Cells were lysed in Laemmli buffer. Proteins were separated on 8% SDS-PAGE gels and transferred to nitrocellulose membrane (Millipore) and probed with custom-made rabbit anti-TRPC5 (T5C3, 1:250 dilution) antibody (Xu et al., 2005b) . Secondary antibody was conjugated with horseradish peroxidase. Membranes were washed with PBS and labeling detected by ECLplus (Amersham).
RT-PCR. Total RNA was isolated from HUVECs using a standard TriReagent protocol and treated with DNase I (Ambion). The isolated RNA was used for cDNA synthesis with oligo-dT primer and AMV reverse transcriptase, and the reaction without reverse transcriptase (no-RT) was set in parallel as a negative control. PCR primer sequences for TRPC5 were CATGACTGGTGGAACC and GTGGGAGTTGGCTGTGAA. Thermal cycling was 40 cycles of 94°C (30 s), 56.6°C (1 min), and 72°C (1 min). PCR products were electrophoresed on 1.5% agarose gels containing ethidium bromide and confirmed by direct sequencing.
TRPC CONFERS MERCURY CYTOTOXICITY
Assay for cell viability/proliferation. The cell viability was determined using WST-1 assay (Roche; Xu et al., 2008b) . WST-1 is a tetrazolium salt and can be cleaved by cellular enzymes, and thus, the assay reflects the metabolic activity of the cells. The overall metabolic activity measured by optical absorption correlates well with the viable cell number as determined by cell counting. Cell proliferation was also observed by direct cell counting with ethidium bromide nucleus staining (Xu et al., 2008b) .
Materials. All general salts and reagents were from Sigma (U.K.) or from British Drug House (Poole, U.K.). Methylmercury chloride (PESTANAL), HgCl 2 , gadolinium chloride (Gd 3þ ), Pb(NO 3 ) 2 , NiCl 2 , ZnCl 2 , hydrogen peroxide, p-chloromercuricbenzene sulfonate sodium salt (pCMBS), dithiothreitol (DTT), dimercaptosuccinic acid (DMSA), 2-aminoethoxydiphenyl borate (2-APB), and bovine serum albumin were purchased from Sigma. Fura-PE3 AM and Fluo-3 AM were from Molecular Probes. Fluo-3 AM or Fura-PE3 AM (5mM) and 2-APB (75mM) were made up as stock solutions in 100% dimethyl sulfoxide, and MeHg (10mM) was dissolved in water.
Statistics. Data are expressed as mean ± SEM, where n is the cell number for electrophysiological recordings. For Ca 2þ assay and cell proliferation study, the number of experiments was given. Data sets were compared using unpaired Student's t-test and ANOVA Dunnett's post hoc analysis with significance indicated if p < 0.05.
RESULTS

Activation of TRPC5 Channels by Mercurial Compounds
To assess the effect of mercury compounds on TRPC channels, the Ca 2þ influx and current were measured in HEK-293 cells stably transfected with TRPC5. The expression of human TRPC5 channel was characterized by the activation by lanthanides and the unique ''N''-shaped IV relationship (Figs. 1A and 1B), which has been previously described (Xu et al., 2005a) . MeHg and divalent mercury (Hg 2þ ) significantly increased the Ca 2þ influx via TRPC5 in a concentrationdependent manner (Figs. 1C-F) . For the acute experiments with accumulative application of mercurial compounds, the EC 50 for MeHg was 2.03lM with a slope of 0.22, and the EC 50 for HgCl 2 was 3.07lM with a slope factor of 0.40. We also observed the effect of a single concentration of MeHg with longer incubation time, and the cytosolic Ca 2þ in the TRPC5-transfected cells was significantly elevated by MeHg at as low as 0.01lM after incubation for 20 min (n ¼ 5, p < 0.001). These results suggested that MeHg is a potent activator of TRPC5.
Mercurial compounds with different ionic charge and/or lipophilicity may have differential effects (Hewett and Atchison, 1992) ; therefore, we compared the divalent mercury (HgCl 2 ), monovalent (MeHg), and organomercurial pCMBS. The pCMBS has been regarded as a cell-impermeable reagent due to its lowest lipophilicity. The current of TRPC5 was significantly activated by pCMBS as well as MeHg and Hg 2þ ( Fig. 2) , suggesting that the activation of TRPC5 channel by mercurial compounds is independent of lipophilicity and ion charge. This also indicated that the binding site to mercurials could be extracellularly accessible.
In addition, we found that the stimulating effect of mercurial compounds on TRPC5 channel was additive to lanthanides.
The rectification property of TRPC5 shown in the IV curve was distorted after perfusion with Hg 2þ (Supplementary fig. 1B ), suggesting that mercurials may have a different extracellular binding site beyond the glutamic acid residues that have been identified as the extracellular binding sites for lanthanides (Jung et al., 2003) . The binding site could be located within the electrical field near the channel pore region.
Extracellular Effect on TRPC Channel
We performed outside-out excised membrane patches and found that the extracellular perfusion with MeHg significantly increased the TRPC5 current (Figs. 3A and 3B ), but no effect if the intracellular surface was exposed to MeHg using the inside-out patch configuration recordings (Fig. 3C) . Similarly, Hg 2þ also showed the external effect (Figs. 3D-F) . The orientation of excised membrane was confirmed by perfusion with 2-APB or Gd 3þ , both of which have been shown to have extracellular effects (Xu et al., 2005a) . These data suggested that the target for mercurial compounds is extracellularly located.
Role of Extracellular Cysteine Residues in the E3 Loop
Sequence alignment and channel topology analysis showed that two cysteine residues (C 553 and C 558 ) are predicted in the third extracellular loop (E3) near the channel pore (Fig. 4A) . The two cysteine residues have the highest probability to form a disulfide bond predicted by the software (Cheng et al., 2006) . The predicted structures with and without disulfide bond between S5 and S6 were shown in Figure 4B . We substituted the two cysteines with alanines (C 553A and C 558A ) and found that the double-cysteine mutant TRPC5 channel (TRPC5 C553A/ C558A ) was in the open state with a high basal activity, which is consistent with our observation (Xu et al., 2008a) . The TRPC5 C553A/C558A mutant channel was resistant to mercury ( Fig. 4C) , suggesting that the two cysteine residues are essential for the action of mercurial compounds. In addition, TRPC5 associates with TRPC1 to form a heteromultimeric TRPC1/5 channel (Strubing et al., 2001; Xu et al., 2006 ); therefore, we tested the mutant TRPC1/5 heteromultimeric channel (TRPC5 C553A/C558A þ TRPC1 C537A ), and no effect was observed (Fig. 4D) . However, these cysteine mutant channels were still sensitive to TRPC5 channel blocker 2-APB.
Effect of Mercurial Compounds on Other TRP Channels
The sensitivity of TRPC to mercury is presumed to be isoform specific because the effect was absent if a TRPC member without cysteine residues was present in the region, for example, TRPC3 and TRPC6 (Figs. 4E and 4F ). TRPV1 and TRPM2 have cysteine residues in the S5-S6 region (C 621 and C 635 for TRPV1, C 994 and C 1006 for TRPM2), but there was no direct channel activation by MeHg (Figs. 4G and 4H ), which suggested that both cysteine position and channel conformation are important 58 for mercury sensitivity. TRPC4 not only has a high identity to TRPC5 in amino acid sequence but also shows functional similarity, such as the sensitivity to lanthanides (Jung et al., 2003) . We found that human TRPC4a was also sensitive to Hg 2þ and the channel activity was blocked by 2-APB (Supplementary  fig. 2 ). However, we were unable to examine TRPC1 due to its relatively small Ca 2þ signal in the transfected cells, which was difficult to distinguish from the endogenous channel signal.
Effect of Other Heavy Metals on TRPC5 Channel
The ion sensitivity of TRPC5 led us to examine other heavy metals. Pb 2þ is another important pollutant in the environment and causes neurodevelopment disorders (Costa et al., 2004) . Pb 2þ at low concentrations (0.01-5lM) had no effect but mildly increased Ca 2þ influx at higher concentrations (Supplementary fig. 3A ). In contrast, Pb 2þ showed an inhibitory effect if the TRPC5 channel is at the opening state (Supplementary fig. 3B ).
TRPC Channel Regulators on Mercury Exposure
We tested the potential of TRP channel blockers for the treatment for mercury exposure. We found that 2-APB, a potent TRPC channel blocker, significantly inhibited the whole-cell current of TRPC5 activated by Hg 2þ (Figs. 5A and 5B). This therapeutic effect was also demonstrated by outside-out excised membrane patch (see Figs. 3A and 3B ). In addition, preincubation of 2-APB fully prevented the channel activation by Hg 2þ (Fig. 5C ). Reducing agents with thiols or dithiols have been used for mercury detoxification (Rooney, 2007 ); therefore, we tested DTT and the therapeutic drug DMSA. Similar to our previous observation (Xu et al., 2008a) , DTT itself displayed channel activation on TRPC5; however, the TRPC5-transfected cells pretreated with DTT resulted in the loss of stimulating action by Hg 2þ , instead of a partial inhibition (Figs. 5D and 5E), suggesting that the reducing environment is important for modifying the action of mercury on TRPC channels. DMSA has been widely used in clinic as a thiol-reducing agent to chelate heavy metal ions. We found DMSA stimulated TRPC5 channels, and DMSA did not prevent the TRPC5 channel activation by Hg 2þ (Supplementary fig. 4 ), suggesting that TRPC channel blocker could be developed as a potential therapeutic drug for mercury poisoning.
Involvement of TRPC in Mercury-Induced Cytotoxicity
We examined the involvement of TRPC5 channel in the cytotoxicity of mercury exposure. The expression of TRPC5 in HEK293 T-REx cells was induced by tetracycline using a tetracycline-regulatory gene expression system. The noninducible cells (without tetracycline) were used as control (Xu et al., 2005a; Zeng et al., 2004) . We found that the overexpression of The IV curve and the mean ± SEM data (I). The n numbers are given in the parentheses. Normalized unit (n.u.) is given as the ratio (after/before treatment) of the current at -60 mV. ANOVA test was used. **p < 0.01 and ***p < 0.001.
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TRPC5 increased the proliferation of HEK-TRx cells by 27.6 ± 3.1% after 24 h cell culture determined by WST-1 assay. Incubation with Hg 2þ at 1 and 5lM inhibited the cell proliferation in both TRPC5-transfected and nontransfected cells, but the inhibitory effect was more evident in the cells overexpressing TRPC5 (Fig. 6A) , suggesting that the enhanced cytotoxicity could be due to the channel opening by Hg 2þ and thus lead to the intracellular toxicological processes through Hg 2þ influx.
To explore the potential protection against mercuryinduced cytotoxicity, the TRPC5-specific blocking antibody and the two nonselective TRPC channel blockers, 2-APB and SKF-96365, were tested (Xu et al., 2005b) . After incubation with Hg 2þ for 24 h, the cell viability was significantly lower (5lM) was applied in the intracellular surface via inside (i)-out patch recordings. Gd 3þ (100lM) had no effect in inside-out membrane orientation because the binding site for Gd 3þ was extracellularly located (Jung et al., 2003; Xu et al., 2005a) . (D) Divalent Hg 2þ (1lM) had a similar channel stimulating effect, and the representative IV curve is shown in (E). (F) Mean data for the outside-out patch experiments (n ¼ 6, * p < 0.05 and ***p < 0.001). The currents in (A), (C), and (D) were given at the potential of ± 80 mV.
TRPC CONFERS MERCURY CYTOTOXICITY in the tetracycline-induced group (TRPC5) than that in the noninduced group (control). 2-APB (75lM) did not show any protective action on the Hg 2þ -evoked cytotoxicity; instead, a deteriorating effect, which could be due to its inhibition on intracellular inositol trisphosphate (IP 3 ) receptors (Szatkowski et al., 2010) . However, SKF-96365 significantly prevented the Hg 2þ -evoked cytotoxicity in the TRPC5-transfected cells (Fig. 6A) . The TRPC5-specific pore-blocking antibody also significantly showed protection against the mercury-induced cytotoxicity (Fig. 6B ). In addition, we examined nonsulfhydryl and sulfhydryl-reducing agents. Tris (2-carboxyethyl) phosphine hydrochloride (TCEP), a membrane-impermeable nonsulfuric ) was also resistant to Hg 2þ (5lM) but sensitive to 2-APB (75lM). (E and F) No effect of Hg 2þ (5lM) on TRPC3 and TRPC6 that has no cysteine residue in the region (n ¼ 5 for each isoform) but sensitive to trypsin (0.1nM) or carbachol (100lM) (Xu et al., 2005a) . The IV curves of before (a) and after treatment with 5lM Hg 2þ (b) and 0.1nM trypsin (c) are shown in the insets. (G and H) TRPM2 (n ¼ 4) and TRPV1 (n ¼ 3) did not display direct channel activation by MeHg (0.01-10lM); however, the expressed channels are sensitive to H 2 O 2 (1mM; McHugh et al., 2003) and capsaicin (1lM). 62 reducing agent that can activate TRPC5 channels (Xu et al., 2008a) , had no protective effect, whereas the membrane-permeable sulfuric reducing agent DTT enhanced the cytotoxicity (Fig.  6C) . DMSA with two thiol groups showed a significant protective effect on cell survival; however, the effect is more evident in the noninduced cells (Fig. 6D) , suggesting that the protective mechanism for DMSA could be due to Hg 2þ chelation, rather than the action on TRPC5 channels. The cell viability in the TRPC5-transfected group was decreased, which could be explained as the direct TRPC4 and TRPC5 channel activation by DMSA (Supplementary fig. 4 ) that may cause more Hg 2þ influx and thus enhance the cytotoxicity via other mechanisms.
TRPC5 is widely expressed in central nervous system and involved in axonal growth (Greka et al., 2003; Hui et al., 2006) . Therefore, we examined the TRPC5 channel in the neurotoxicity of mercury exposure. We found that the NGFinduced axonal growth was dramatically inhibited by mercurial compounds in a neuronal cell line (PC12), whereas Pb 2þ at 1lM had no effect on axonal growth (Fig. 7A) . The cell proliferation was also inhibited (Fig. 7B) . Transfection with TRPC5 siRNA inhibited cell proliferation and axonal extension and partially alleviated Hg 2þ -induced cytotoxicity (Figs. 7C  and 7D ).
Massive loss of cerebral cortex is another important pathological change in patients with mercury poisoning, and microvasculature formation is critical for maintaining the thickness of cerebral cortex (Eto and Takeuchi, 1978) ; we therefore tested the vascular hypothesis using endothelial cells derived from newborns. As shown in Figure S5A , TRPC5 was highly expressed in HUVECs. The cell growth of HUVECs was substantially inhibited by Hg 2þ and MeHg, but not by Pb 2þ . Inhibition of TRPC5 expression by TRPC5 siRNA also prevented the cell proliferation inhibition induced by 1lM Hg 2þ (Supplementary fig. 5 ), suggesting that the Ca 2þ -overloaded mechanism of mercury exposure via TRPC activation could be extended to vascular system. Our results provide first evidence that mercurial compounds can activate TRPC5 channels. The action site is related to the two extracellular cysteine residues (C 553 and C
558
) near the channel pore. The blockade of TRPC channel by 2-APB not only prevents the channel activation evoked by mercurial compounds but also shows therapeutic effect against the channel activation by mercury. TRPC channel blockers (SKF-96365 and TRPC5 pore-blocking antibody) modestly alleviate the cytotoxicity. These results give a new insight of TRPC4 and TRPC5 as the target proteins of mercury toxicity and a clue for the development of TRPC channel blockers as new therapeutic agents for mercury exposure.
The sensitivity of TRPC5 channels to trivalent lanthanides (La 3þ or Gd 3þ ) has been described by Jung et al. (2003) ; however, the physiological or pathophysiological significance of the trivalent sensitivity of TRPC5 channel is unclear, especially lanthanides are very rare elements in the human body except their chelating complexes used as diagnostic and therapeutic agents (Bottrill et al., 2006; Kostova, 2005) . Therefore, we screened other heavy metal ions. Interestingly, we found that TRPC5 channel is sensitive to mercurial compounds. The channel can be activated by mercurials at micromolar concentrations, suggesting that TRPC5 channel is a novel target for mercury exposure. We examined the binding sites using excised membrane patch clamp and site mutagenesis and identified that two cysteine residues in the third extracellular loop of transmembrane region mediate the channel activation. This result suggested that there are at least two extracellular binding sites for heavy metal ions in TRPC5, that is, the two cysteine residues (C 553 and C 558 ) bound to mercurial compounds and the glutamic acid residues (Glu 543 and Glu 595 /Glu 598 ) for lanthanides (Jung et al., 2003) . Although nearly all ion channel proteins contain cysteine residues and the cytotoxicity of mercurials has been related to the formation of stable complexes with sulfhydryl-containing amino acids (Carvalho et al., 2008; Rooney, 2007) , the effect of mercurials is still specific for some ion channels; for (Xu et al., 2005b) . Boiled TRPC5-Ab was used as control. (C) The reducing agents TCEP (100lM) and DTT (1mM) were used. The cells were incubated with Hg 2þ for 24 h with and without reducing agents (n ¼ 16 wells for each group). (D) Cells were incubated with and without chelating agent DMSA (100lM) for 24 h (n ¼ 16 wells for each group). *p < 0.05; **p < 0.01; ***p < 0.001. 64 example, TRPC3 and TRPC6 without extracellular cysteine residues did not show any sensitivity to mercurial compounds; TRPM2 or TRPV1 with cysteine residues at different positions showed no direct activation, suggesting that the effect of mercurials on TRP channels is determined by the location and function of individual cysteine residue in a protein. This hypothesis needs to be further tested on other TRP channels in the future. In addition, we found that the action of mercury on TRPC5 channel could be modified by reducing agents. These findings suggested that both the cysteine residue position and channel conformation are important for mercury activation on TRP channels.
Several types of VGCC have been shown to be inhibited by mercurial compounds, such as L-type and T-type (Hajela et al., 2003; Tarabova et al., 2006) ; however, the cytosol [Ca 2þ ] was increased in cells treated with mercury (Limke et al., 2004) . The activation of TRPC5 channel found in this study provides a good explanation for the increased [Ca 2þ ] i seen in mercury exposure. Although we tested TRPM2 in the TRPM subfamily and TRPV1 in the TRPV subfamily, we were unable to examine all the members in TRP superfamily; however, the sequence alignment of TRP superfamily shows no similar location of cysteine residues in the S5-S6 regions (see Supplementary fig. 1C ), suggesting that the TRPC5 or TRPC4 in TRPC subfamily is probably the only isoform for mercury activation.
The potential protective effect on the mercury cytotoxicity was examined in this study using in vitro cell models. The more evident inhibition on cell proliferation was seen in the TRPC5 overexpressing cells, which could be due to the channel activation and thus facilitates Hg 2þ and Ca 2þ influxes. The TRPC channel blocker 2-APB can potently protect against the channel-stimulating effect by mercurial compounds; however, there was no protective effect against cytotoxicity, which could be explained by the additional effects of 2-APB on cell survival, such as the inhibition on IP 3 receptor (Xu et al., 2005a) or the blockage on gap junctional channel (Bai et al., 2006) . However, SKF-96365, another nonselective TRPC channel blocker, showed a significantly protective effect, suggesting that TRPC channel blocker may be useful for the treatment of mercury exposure. Importantly, we found that TRPC5-blocking antibody specifically prevented the cytotoxicity induced by mercury, which provided the direct evidence of TRPC5 acting as a therapeutic target for mercury TRPC CONFERS MERCURY CYTOTOXICITY exposure. The protective effects are modest, which suggest that other toxicological mechanisms are also important, for example, the intracellular mechanisms (Calamita et al., 2005; Castoldi et al., 2000) . On the other hand, thiol chemicals or thiol-containing proteins have been investigated for the treatment of mercury toxicity (Patrick, 2002) . The reducing agents DTT and TCEP that can activate TRPC5 channel (Xu et al., 2008a) did not show any protective effects, whereas DMSA, a chelating thiol agent with stimulating action on TRPC5 and TRPC4 channels, showed a nonselective protection. These results may give the explanations why mercury detoxification with reducing agents is not very effective.
Numerous studies have demonstrated that exposure to mercurial compounds causes neurodevelopmental disorders. Therefore, we examined the neuronal cell growth and the role of TRPC channels in mercury-induced neurotoxicity. We found that mercurial compounds significantly inhibited the PC 12 cell growth and axonal extension; this result is consistent with other reports (Leong et al., 2001; Radio et al., 2008) . The inhibition on axonal extension and cell proliferation by Hg 2þ was alleviated when the TRPC5 gene was silenced by the specific TRPC5 siRNA (Xu et al., 2008a) , suggesting that the TRPC5 channel mediates the mercury neurotoxicity. On the other hand, the inhibition of VGCC has no direct relevance to the impairment of IQ or intelligence but rather to an improvement of memory or recognition (Veng et al., 2003) ; therefore, we suppose that the IQ loss due to mercury exposure might be caused by the elevated [Ca 2þ ] i through TRPC5 activation and consequently affecting growth cone formation, axonal extension, and the connections between synapses. We also confirm the hypothesis that mercury cytotoxicity is mediated by TRPC5 channel in the vascular endothelial cells where the expression level of TRPC5 is high.
According to the U.S. Environment Protection Agency's reference dose, the level of mercury in blood less than 5.8 lg/l (equivalent to 0.029lM) has been considered ''safe'' without causing adverse health effects (Hightower et al., 2006; Weil et al., 2005) , although it has been argued that the concentration should be lowered to 3.5 lg/l (Hightower et al., 2006) . In this study, we found that longer incubation with 10nM MeHg slightly increased Ca 2þ influx and Hg 2þ at 100nM significantly increased the outside-out patch current of TRPC5, which suggests that the effect of mercurial compounds on TRPC channel activity could happen in the population with elevated blood mercury level. In addition, the distribution and disposition of mercurial compounds in the body are tissue and organ specific; for example, the concentration of MeHg in brain is much higher than in plasma (50 times; Cernichiari et al., 2007) . Higher level (> 5.8 lg/l) of mercury has also been reported in the population living in polluted areas and frequent fish consumers . Therefore, the novel toxicological mechanism we reported here should be applicable for all cases of mercury overexposure. The removal of MeHg in the body is difficult, presumably due to its enterohepatic recirculation and poor reaction with chelating agents; therefore, the search for specific TRPC channel blockers may give rise to new therapeutics for mercury poisoning.
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